<DOC>
	<DOCNO>NCT01390207</DOCNO>
	<brief_summary>The effect alter time hCG administration ongoing pregnancy rate patient stimulate recombinant-FSH ( rec-FSH ) /gonadotrophin release hormone ( GnRH ) antagonists vitro fertilisation ( IVF ) .</brief_summary>
	<brief_title>Earlier Triggering Rec-FSH/GnRH Antagonist Cycles</brief_title>
	<detailed_description>Progesterone elevation associate prolongation follicular phase GnRH antagonists cycle two day commonly use criterion presence least three follicle &gt; or= 17 mm meet . Such intervention associate significantly low ongoing pregnancy rate GnRH antagonist cycle , without apparent deterioration embryo quality . The adverse effect P elevation day hCG administration might explain induction difference histological level well gene expression level endometrial sample expose vary concentration progesterone ( P ) . Prolongation follicular phase delay hCG administration two day associate high incidence endometrial advancement day oocyte retrieval GnRH antagonist cycle ( Kolibianakis et al. , 2005 ) . Moreover , Vaerenbergh et al. , ( 2011 ) demonstrate distinct difference endometrial gene expression profile patient progesterone serum concentration threshold 1.5 ng/ml day HCG administration . Due fact earlier trigger final oocyte maturation expect result lower progesterone level day hCG administration might assume intervention might result improved probability pregnancy lead less deranged receptive endometrium . The purpose randomize control trial evaluate whether trigger final oocyte maturation soon ≥ 3 follicle ≥ 16mm present ultrasound one day later affect probability pregnancy patient stimulate rec-FSH/GnRH- antagonist IVF .</detailed_description>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>Age ≤ 39 year Body mass index 18 29 kg/m²¬ Presence ovary Basal level estradiol ( ≤ 80 pg/ml ) progesterone ( ≤ 1.6ng/ml ) day one cycle Treatment IVF/ICSI Embryo transfer day 3 ( 1 2 embryo ) Patients enter study Presence endometriosis stage ≥3 ( AFS ) Polycystic ovarian syndrome ( Rotterdam criterion ) Need preimplantation genetic diagnosis ( PGD ) Azoospermia testicular sperm extraction ( TESE )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>hCG trigger</keyword>
	<keyword>pregnancy</keyword>
	<keyword>GnRH antagonist</keyword>
</DOC>